| 7/13/2021 |
Perimeter Medical Imaging AI Further Strengthens Management Team with Appointment of Dr. Sarah Butler as Vice President, Clinical & Medical Affairs | Financial Buzz |
financialbuzz.com |
... ÄúWe are thrilled to welcome Dr. Sarah Butler to our team whose expertise in medical affairs and clinical strategy will be a great asset for Perimeter. As we approach launching our pivotal study for clinical validation of our ImgAssist AI software and look towards what is next for our exciting technology, Sarah will provide executive leadership of the development and execution of clinical strategies that establish and expand upon our ... |
| 7/8/2021 |
Exicure Announces Upcoming Neuroscience Pipeline Update at Virtual R&D Day | Business Wire |
Business Wire |
... with XCUR-FXN, which is on track for IND filing in late Q4 2021. Additionally, Exicure will discuss its perspective on XCUR-FXN’s competitive differentiation in FA and the program’s path to clinical validation .Also, Exicure will provide an update on its expanding pipeline across several rare neurodegenerative diseases of high unmet need and highlight progress with two preclinical programs targeting SCN9A (Na v 1.7) for neuropathic pain ... |
| 7/8/2021 |
Exicure Announces Upcoming Neuroscience Pipeline Update at Virtual R&D Day | Financial Buzz |
financialbuzz.com |
... with XCUR-FXN, which is on track for IND filing in late Q4 2021. Additionally, Exicure will discuss its perspective on XCUR-FXN’s competitive differentiation in FA and the program’s path to clinical validation .Also, Exicure will provide an update on its expanding pipeline across several rare neurodegenerative diseases of high unmet need and highlight progress with two preclinical programs targeting SCN9A (Na v 1.7) for neuropathic pain ... |
| 7/7/2021 |
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer |
biomedcentral.com |
Primary research - Open Access - Published:] Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer [Cancer 359 (2021) [Cite this article 1 Altmetric - Abstract Background A large number of patients with stage II/III colorectal cancer (CRC) have a high recurrence rate after radical resection. We aimed to develop a novel tool to stratify patients ... |
| 7/1/2021 |
Scientific Breakthrough in Alzheimer's Treatment is Here |
PR Newswire |
BURLINGAME, Calif. Recent clinical validation of Apollo Health's ReCODE Protocol ™ — an intervention designed to reverse cognitive decline — could finally bring relief to millions who suffer from dementia. That validation comes from early results of a clinical trial based upon the science of Dale Bredesen , M.D. and recently shared in a pre-print entitled Precision Medicine Approach to Alzheimer ' s Disease: Successful Proof-of-Concept Trial , posted in ... |
| 7/1/2021 |
Genedrive provides positive update on Covid-19 test kit | 1 July 2021 | Stock Market Wire |
stockmarketwire.com |
Diagnostics company Genedrive provided a positive update its Covid-19 test kit.The test kit overcame 'significant' technical hurdles and had also made further improved performance specifications relating to sensitivity, specificity, speed, ease of use, and scalability.'Full clinical validation on patient specimens is required for regulatory registration and/or other emergency listings,' the company said.'The company is optimistic that this can be completed successfully and is targeting CE ... |
| 7/1/2021 |
New cardiac MRI protocol enables faster scans, possibly expanding use in clinical practice |
healio.com |
... this issue please contact [email protected] . Back to HealioA novel cardiac MRI technology greatly reduced the amount of time it takes for a scan, potentially lifting a barrier to use, researchers reported.A clinical validation study of a protocol using the ultrafast technology (Enhanced Sensitivity Coding by Static Outer Volume Subtraction [ESSOS], Philips), which captures 3D images while requiring only a few breath holds from patients, was published in ... |
| 7/1/2021 |
Abstract CT181: Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC |
aacrjournals.org |
... popup Citation Format: Joshua M. Bauml, Bob T. Li, Vamsidhar Velcheti, Ramaswamy Govindan, Alessandra Curioni Fontecedro, Christophe Dooms, Toshiaki Takahashi, Andrew W. Duda, Justin Odegaard, Fernando Cruz-Guilloty, Liming Jin, Ying Zhang, Ferdinandos Skoulidis. Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting ... |
| 6/29/2021 |
Cognivue Clarity Compared to MoCA in Published Study |
hearingreview.com |
Neuroscience company Cognivue, Inc announced the publication of its clinical validation study showing its technology “equally as effective as the Montreal Cognitive Assessment (MoCA) with superior test-retest reliability.” The peer-reviewed paper is now available via open access from Neurological Sciences and Neurosurgery .1 Related article: Cognivue CEO Tom O’Neill Joins Milken Institute Committee Cognivue technologies are designed to provide healthcare providers a useful tool for cognitive ... |
| 6/29/2021 |
Cizzle Biotechnology makes 'significant progress' with CIZ1B biomarker test for lung cancer detection |
stockmarketwire.com |
... the development of its prototype CIZ1B biomarker test for the early detection of lung cancer, the company had now 'selected manufacturers and contract research organisations to conduct the required reagent generation, test manufacture and clinical validation to achieve CE marking and FDA 510(k) clearance for the [prototype CIZ1B biomarker] test,' the company said.The company had also commenced a 'robust health economics exercise to establish that the test satisfies ... |
| 6/28/2021 |
NEW JERSEY Latino News |
newjerseylatinonews.com |
... with agility, expertise and determination."Michael B. Raizman , M.D. , Palatin's newly appointed Chief Medical Officer will report directly to Dr. Spana. Dr. Raizman will provide leadership and direction across the entire product pipeline, including clinical validation , medical and regulatory affairs, and overall clinical, medical, and regulatory activities. In addition to joining Palatin, Dr. Raizman is a physician with Ophthalmic Consultants of Boston and a Diplomate of the American Board of ... |
| 6/12/2021 |
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors |
hindawi.com |
... The Ki-67 index has been used for decades to evaluate mitotic counts however, the role of Ki-67 as a biomarker for assessing prognosis and guiding therapy in metastatic LNET still lacks feasible clinical validation . Recent clinical trials have indicated that inhibition of CD47 with anti-CD47 antibodies exerts a promising antitumor effect against several human malignancies, including NSCLC, melanoma, and hematologic malignancies. However, the clinical relevance of CD47 ... |